Format

Send to

Choose Destination
Br J Cancer. 2007 Jan 15;96(1):11-5.

Cancer risks among BRCA1 and BRCA2 mutation carriers.

Author information

1
Institute of Medical Genetics, Shaare Zedek Medical Center, Hebrew University Medical School, Jerusalem, 91031, Israel. lahad@szmc.org.il

Abstract

BRCA1 and BRCA2 mutations increase breast and ovarian cancer risks substantially enough to warrant risk reduction surgery, despite variable risk estimates. Underlying this variability are methodological issues, and also complex genetic and nongenetic effects. Although many modifying factors are unidentified, known factors can already be incorporated in individualised risk prediction.

PMID:
17213823
PMCID:
PMC2360226
DOI:
10.1038/sj.bjc.6603535
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Nature Publishing Group Icon for PubMed Central
Loading ...
Support Center